nVent Electric plc Free cash flow decreased by 70.4% to $49.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.6%, from $39.10M to $49.10M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 2.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $85.40M | $107.50M | $100.90M | -$4.60M | $47.70M | $125.90M | $185.10M | $52.30M | $62.00M | $132.50M | $215.70M | $74.70M | $114.30M | $182.00M | $198.10M | $39.10M | -$33.80M | $200.90M | $165.70M | $49.10M |
| QoQ Change | — | +25.9% | -6.1% | -104.6% | >999% | +163.9% | +47.0% | -71.7% | +18.5% | +113.7% | +62.8% | -65.4% | +53.0% | +59.2% | +8.8% | -80.3% | -186.4% | +694.4% | -17.5% | -70.4% |
| YoY Change | — | — | — | — | -44.1% | +17.1% | +83.4% | >999% | +30.0% | +5.2% | +16.5% | +42.8% | +84.4% | +37.4% | -8.2% | -47.7% | -129.6% | +10.4% | -16.4% | +25.6% |